1. Home
  2. LYRA vs CLWT Comparison

LYRA vs CLWT Comparison

Compare LYRA & CLWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LYRA
  • CLWT
  • Stock Information
  • Founded
  • LYRA 2005
  • CLWT 1971
  • Country
  • LYRA United States
  • CLWT Hong Kong
  • Employees
  • LYRA N/A
  • CLWT N/A
  • Industry
  • LYRA Medical/Dental Instruments
  • CLWT Professional and commerical equipment
  • Sector
  • LYRA Health Care
  • CLWT Consumer Discretionary
  • Exchange
  • LYRA Nasdaq
  • CLWT Nasdaq
  • Market Cap
  • LYRA 11.3M
  • CLWT 9.4M
  • IPO Year
  • LYRA 2020
  • CLWT 1997
  • Fundamental
  • Price
  • LYRA $6.85
  • CLWT $1.40
  • Analyst Decision
  • LYRA Hold
  • CLWT
  • Analyst Count
  • LYRA 1
  • CLWT 0
  • Target Price
  • LYRA $16.00
  • CLWT N/A
  • AVG Volume (30 Days)
  • LYRA 14.2K
  • CLWT 23.7K
  • Earning Date
  • LYRA 08-12-2025
  • CLWT 04-30-2025
  • Dividend Yield
  • LYRA N/A
  • CLWT N/A
  • EPS Growth
  • LYRA N/A
  • CLWT N/A
  • EPS
  • LYRA N/A
  • CLWT 0.10
  • Revenue
  • LYRA $770,000.00
  • CLWT $15,383,000.00
  • Revenue This Year
  • LYRA N/A
  • CLWT N/A
  • Revenue Next Year
  • LYRA $123.46
  • CLWT N/A
  • P/E Ratio
  • LYRA N/A
  • CLWT $14.51
  • Revenue Growth
  • LYRA N/A
  • CLWT N/A
  • 52 Week Low
  • LYRA $3.81
  • CLWT $1.01
  • 52 Week High
  • LYRA $37.50
  • CLWT $1.70
  • Technical
  • Relative Strength Index (RSI)
  • LYRA 42.34
  • CLWT 64.33
  • Support Level
  • LYRA $6.91
  • CLWT $1.32
  • Resistance Level
  • LYRA $7.50
  • CLWT $1.55
  • Average True Range (ATR)
  • LYRA 0.33
  • CLWT 0.08
  • MACD
  • LYRA 0.06
  • CLWT 0.01
  • Stochastic Oscillator
  • LYRA 16.18
  • CLWT 55.39

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

About CLWT Euro Tech Holdings Company Limited

Euro Tech Holdings Co Ltd is a distributor and manufacturer of technology instruments as well as an environmental engineering services provider. It is engaged in the marketing and trading of water and wastewater related process control, analytical and testing instruments, disinfection equipment, supplies, and related automation systems. There are two operating segments of the company. The Trading and manufacturing segment, which is the key revenue driver, includes distribution of water treatment equipment, laboratory instruments, analyzers, test kits, and related supplies and power generation equipment. The Engineering segment includes water and waste-water treatment engineering and air pollution control business. The majority of the revenue is generated from Hong Kong.

Share on Social Networks: